XML 28 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stockholders' equity (deficit) (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 14, 2015
May. 08, 2015
Jul. 31, 2015
Oct. 24, 2014
Mar. 31, 2014
Sep. 30, 2015
Jun. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Mar. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Allocated Share-based Compensation Expense           $ 261,540   $ 24,977 $ 1,172,231 $ 80,457    
Debt Conversion, Converted Instrument, Amount                 300,000 0    
Stock Purchase Warrants Issued Upon Conversion Over Allotment Option   422,500                    
Proceeds from Issuance of Warrants   $ 4,225                    
Proceeds From Issuance Of Units Under Initial Public Offering Gross   17,100,000                    
Proceeds From Issuance Of Units Under Initial Public Offering Net   $ 12,100,000                    
Stock Issued During Period, Value, Acquisitions                 $ 2,584,090 0    
Merck Global Health Innovation Fund LLC [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock Issued During Period, Shares, New Issues     1,136,364                  
Over-Allotment Option [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   3,272,500                    
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 6.60                    
Expiration Date of Warrants Issued   May 08, 2020                    
Demand Notes Payable [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Debt Conversion, Converted Instrument, Amount   $ 2,100,000                    
2015 Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized           1,355,000     1,355,000      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant           528,890     528,890      
Share-based Compensation Arrangement by Share-based Payment Award, Common stock Pecentage                 4.00%      
Stock Purchase Warrants Issued             3,457,750          
Stock options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Allocated Share-based Compensation Expense           $ 261,540   $ 24,977 $ 1,172,231 $ 80,457    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                 1,660,387      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                 $ 2.87      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value                 $ 3.16      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number           1,948,249     1,948,249      
Restricted stock units                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period         130,640              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period       130,640                
Warrant                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Class of Warrant or Right, Outstanding           3,716,355     3,716,355     33,594
Common Stock [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock and Warrants Issued in Conjunction with Initial Public Offering   2,850,000                    
Offering Price Per Unit   $ 6.00                    
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 2,900,000                    
Convertible Preferred Stock, Shares Issued upon Conversion   7,374,852         7,374,852          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                     225,011  
Proceeds From Issuance Of Units Under Initial Public Offering Gross   $ 17,100,000                    
Proceeds From Issuance Of Units Under Initial Public Offering Net   $ 12,100,000                    
Common Stock [Member] | Merck Global Health Innovation Fund LLC [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock Issued During Period, Value, Acquisitions $ 5,000,000                      
Common Stock [Member] | Over-Allotment Option [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   185,250